PIK3CA and neoplasm: Progression of prostate cancer and multi-drug-resistant tumour was significantly associated with PI3kinase pathway hyperactivation, either due to PTEN modulation or due to hyperactivation of PIK3CA, AKT, mTOR or any other proteins of the pathway 21.